Anavex Shares (NASDAQ: AVXL) Plunge after Q4 Earnings Miss

Shares of biotech firm Anavex Life Sciences Corp. (NASDAQ: AVXL) fell more than 17% in today’s trading session. This can be attributed to its Q4 earnings results.

The company currently has no sales, meaning that analysts are estimating its cash burn. Earnings per share came in at -$0.18, which was lower than the -$0.17 that was expected.

Is AVXL Stock a Good Investment?

AVXL stock has a Strong Buy consensus rating based on four Buys assigned in the past three months. The average AVXL stock price target of $39.25 implies almost 300% upside potential.


Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More